Scinai Immunotherapeutics Ltd. (SCNI) — SC 13G/A Filings
All SC 13G/A filings from Scinai Immunotherapeutics Ltd.. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (4)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Aug 20, 2024
-
Daniel E. Stone Discloses 12.96% Stake in Scinai Immunotherapeutics
— Jan 24, 2024
Daniel E. Stone, an individual investor, has filed an Amendment No. 2 to Schedule 13G, reporting a beneficial ownership of 624,000 Ordinary ADS Shares in Scinai -
Sabby Volatility Fund Discloses 220,663 Scinai Immunotherapeutics ADSs
— Jan 2, 2024
Sabby Volatility Warrant Master Fund, Ltd., a Cayman Islands-based entity, filed an amended SC 13G/A on January 2, 2024, disclosing its beneficial ownership in
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX